Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

$1,000 a Pop: How Forest Labs Bribed Doctors to Prescribe Antidepressants to Kids
BNET Pharma
Friday, September 17, 2010 - 11:50am
tags:
Forest Labs, kickbacks, antidepressants, Celexa, Lexapro
Hospital Says Astellas Is A Monopolistic Bully
Pharmalot
Friday, September 17, 2010 - 11:49am
tags:
hospitals, Astellas, Adenoscan
Drugs, Drugs Everywhere: CRXL Soars, ARNA Plunges
Barron's
Friday, September 17, 2010 - 11:47am
tags:
Arena Pharmaceuticals, FDA, JNJ, Crucell, M&A
J&J and P&G Stock: Bearish or Bullish?
TheStreet.com
Friday, September 17, 2010 - 11:10am
tags:
P&G, JNJ
Optimer's Fidaxomicin Encourages
Yahoo/Zacks.com
Friday, September 17, 2010 - 11:09am
tags:
Optimer, fidaxomicin, Clostridium Difficile
Why AEterna Zentaris Is Worth Double
Seeking Alpha
Friday, September 17, 2010 - 11:06am
tags:
Aeterna Zentaris, Keryx, Shionogi, Spectrum Pharmaceuticals
Elan set to bolster reporting standards
FT.com
Friday, September 17, 2010 - 11:01am
tags:
Elan
Roche rules out merging R&D units
Reuters
Friday, September 17, 2010 - 11:00am
tags:
R&D, Roche
FDA Panel Votes Against Arena’s Weight-Loss Drug Lorcaserin
WSJ Online
Friday, September 17, 2010 - 7:21am
tags:
Arena Pharmaceuticals, obesity, FDA, advisory panels
Chief of Unit With Recalls to Exit J.&J.
NY Times, NY
Friday, September 17, 2010 - 7:19am
tags:
JNJ, recalls
Pfizer seeking to boost animal health sales
Yahoo/AP
Friday, September 17, 2010 - 7:18am
tags:
Pfizer, animal health
Layoffs Look Likely in Sanofi’s Future
BNET Pharma
Friday, September 17, 2010 - 7:17am
tags:
layoffs, Sanofi, generics, Lovenox, blood thinners
J&J in Talks to Buy Rest of Crucell for $2.3B
TheStreet.com
Friday, September 17, 2010 - 6:36am
tags:
Crucell, JNJ, M&A
Peter Rost Loses Whistleblower Suit Against Pfizer
Pharmalot
Thursday, September 16, 2010 - 12:36pm
tags:
Peter Rost, whistleblowers, Pfizer, Genotropin, off-label
Bayer Chief Envisions $15 Billion Market for Xarelto, New Blood Thinners
Bloomberg
Thursday, September 16, 2010 - 12:29pm
tags:
Bayer, Xarelto, blood thinners, anti-clotting, JNJ, Pfizer, Boehringer Ingelheim, Bristol-Myers Squibb, Pradaxa
In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer
Motley Fool
Thursday, September 16, 2010 - 12:24pm
tags:
Cypress Bioscience, Ramius, M&A
Arena Pharma: FDA Panel Live Blog
TheStreet.com
Thursday, September 16, 2010 - 12:18pm
tags:
FDA, advisory panels, Arena Pharmaceuticals, obesity, Orexigen, Abbott Laboratories, Contrave, Meridia
Do These Health-Care Companies Pass Buffett's Test?
Motley Fool
Thursday, September 16, 2010 - 12:17pm
tags:
Warren Buffett, Baxter International, Abbott Laboratories, Eli Lilly
AstraZeneca Pensions: CEO, Yes - Workers, No
Seeking Alpha
Thursday, September 16, 2010 - 12:16pm
tags:
AstraZeneca, pensions, executive pay
Glaxo and Genmab drop IV version of immune drug
Yahoo/AP
Thursday, September 16, 2010 - 12:15pm
tags:
GSK, Genmab, Arzerra, autoimmune disease, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.